help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Leclerc, P. C.
Right arrow Articles by Guillemette, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Leclerc, P. C.
Right arrow Articles by Guillemette, G.
Endocrinology Vol. 143, No. 12 4702-4710
Copyright © 2002 by The Endocrine Society


ARTICLE

A Polyaromatic Caveolin-Binding-Like Motif in the Cytoplasmic Tail of the Type 1 Receptor for Angiotensin II Plays an Important Role in Receptor Trafficking and Signaling

Patrice C. Leclerc, Mannix Auger-Messier, Pascal M. Lanctot, Emanuel Escher, Richard Leduc and Gaétan Guillemette

Department of Pharmacology, Faculty of Medicine, Université de Sherbrooke, Sherbrooke, Québec, Canada J1H 5N4

Address all correspondence and requests for reprints to: Gaétan Guillemette, Ph.D., Department of Pharmacology Faculty of Medicine, Université de Sherbrooke, 3001 12th Avenue North, Sherbrooke (Québec), J1H 5N4, Canada. E-mail: Gaetan.Guillemette{at}USherbrooke.ca.

The type 1 receptor for angiotensin II (AT1) is a member of the G protein-coupled receptor family. The presence of a caveolin-binding-like motif ({phi}X{phi}XXXX{phi}XX{phi} where {phi} is an aromatic residue) within the cytoplasmic tail of the AT1 receptor suggests an implication for caveolae in the functionality of this receptor. We constructed a mutant AT1 receptor where each of the aromatic residues in the caveolin-binding-like motif were replaced by alanine (AT1-YFFY/A). Mutation of this motif considerably reduced the plasma membrane expression of the receptor that accumulated in a perinuclear compartment. The agonist-induced internalization rate of the AT1-YFFY/A receptor was also significantly reduced. Finally, the AT1-YFFY/A receptor was poorly activated as indicated by a low agonist-induced production of inositol phosphates. Unexpectedly, the proportion of AT1 receptor found in caveolae was minor under basal conditions and did not increase under stimulated conditions. Coexpression of the AT1 receptor with dopamine receptor interacting protein of 78 kDa, a protein implicated in the cellular routing of the dopamine D1 receptor, increased plasma membrane expression of the AT1 receptor. However, dopamine receptor interacting protein of 78 kDa had no effect on the expression of the AT1-YFFY/A receptor. Taken together, these results suggest that the caveolin-binding-like motif of the AT1 receptor does not promote localization of the receptor to caveolae but rather may act as a docking site for regulatory proteins modulating the routing and the functionality of the receptor.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
D. J. Dupre, M. Robitaille, M. Richer, N. Ethier, A. M. Mamarbachi, and T. E. Hebert
Dopamine Receptor-interacting Protein 78 Acts as a Molecular Chaperone for G{gamma} Subunits before Assembly with Gbeta
J. Biol. Chem., May 4, 2007; 282(18): 13703 - 13715.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
C. A. Syme, L. Zhang, and A. Bisello
Caveolin-1 Regulates Cellular Trafficking and Function of the Glucagon-Like Peptide 1 Receptor
Mol. Endocrinol., December 1, 2006; 20(12): 3400 - 3411.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
L. Hunyady and K. J. Catt
Pleiotropic AT1 Receptor Signaling Pathways Mediating Physiological and Pathogenic Actions of Angiotensin II
Mol. Endocrinol., May 1, 2006; 20(5): 953 - 970.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
L. Zuo, M. Ushio-Fukai, S. Ikeda, L. Hilenski, N. Patrushev, and R. W. Alexander
Caveolin-1 Is Essential for Activation of Rac1 and NAD(P)H Oxidase After Angiotensin II Type 1 Receptor Stimulation in Vascular Smooth Muscle Cells: Role in Redox Signaling and Vascular Hypertrophy
Arterioscler. Thromb. Vasc. Biol., September 1, 2005; 25(9): 1824 - 1830.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
C. J. Wruck, H. Funke-Kaiser, T. Pufe, H. Kusserow, M. Menk, J. H. Schefe, M. L. Kruse, M. Stoll, and T. Unger
Regulation of Transport of the Angiotensin AT2 Receptor by a Novel Membrane-Associated Golgi Protein
Arterioscler. Thromb. Vasc. Biol., January 1, 2005; 25(1): 57 - 64.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
B. N. Becker, H.-f. Cheng, T. G. Hammond, and R. C. Harris
The Type 1 Angiotensin II Receptor Tail Affects Receptor Targeting, Internalization, and Membrane Fusion Properties
Mol. Pharmacol., February 1, 2004; 65(2): 362 - 369.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. D. Wyse, I. A. Prior, H. Qian, I. C. Morrow, S. Nixon, C. Muncke, T. V. Kurzchalia, W. G. Thomas, R. G. Parton, and J. F. Hancock
Caveolin Interacts with the Angiotensin II Type 1 Receptor during Exocytic Transport but Not at the Plasma Membrane
J. Biol. Chem., June 20, 2003; 278(26): 23738 - 23746.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2002 by The Endocrine Society